<!DOCTYPE html>
<html lang="en">
    <head>
        <meta charset="utf-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">
        
        
        
        <link rel="shortcut icon" href="../../img/favicon.ico">
        <title>Lymphoma - MediWiki</title>
        <link href="../../css/bootstrap.min.css" rel="stylesheet">
        <link href="../../css/font-awesome.min.css" rel="stylesheet">
        <link href="../../css/base.css" rel="stylesheet">
        <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/11.8.0/styles/color-brewer.min.css">
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/11.8.0/highlight.min.js"></script>
        <script>hljs.highlightAll();</script> 
    </head>

    <body>
        <div class="navbar fixed-top navbar-expand-lg navbar-dark bg-primary">
            <div class="container">
                <a class="navbar-brand" href="../..">MediWiki</a>
                <!-- Expander button -->
                <button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#navbar-collapse">
                    <span class="navbar-toggler-icon"></span>
                </button>

                <!-- Expanded navigation -->
                <div id="navbar-collapse" class="navbar-collapse collapse">
                        <!-- Main navigation -->
                        <ul class="nav navbar-nav">
                            <li class="navitem">
                                <a href="../../Basic%20Clinical%20Sciences.html" class="nav-link">Basic Clinical Sciences</a>
                            </li>
                            <li class="navitem">
                                <a href="../../Internal%20Medicine.html" class="nav-link">Internal Medicine</a>
                            </li>
                            <li class="navitem">
                                <a href="../../Surgery.html" class="nav-link">Surgery</a>
                            </li>
                            <li class="navitem">
                                <a href="../../Psychiatry.html" class="nav-link">Psychiatry</a>
                            </li>
                            <li class="navitem">
                                <a href="../../Critical%20Care.html" class="nav-link">Critical Care</a>
                            </li>
                        </ul>

                    <ul class="nav navbar-nav ml-auto">
                        <li class="nav-item">
                            <a href="#" class="nav-link" data-toggle="modal" data-target="#mkdocs_search_modal">
                                <i class="fa fa-search"></i> Search
                            </a>
                        </li>
                            <li class="nav-item">
                                <a rel="prev" href="Hodgkin%27s%20lymphoma.html" class="nav-link">
                                    <i class="fa fa-arrow-left"></i> Previous
                                </a>
                            </li>
                            <li class="nav-item">
                                <a rel="next" href="Multiple%20Myeloma.html" class="nav-link">
                                    Next <i class="fa fa-arrow-right"></i>
                                </a>
                            </li>
                    </ul>
                </div>
            </div>
        </div>

        <div class="container">
            <div class="row">
                    <div class="col-md-3"><div class="navbar-light navbar-expand-md bs-sidebar hidden-print affix" role="complementary">
    <div class="navbar-header">
        <button type="button" class="navbar-toggler collapsed" data-toggle="collapse" data-target="#toc-collapse" title="Table of Contents">
            <span class="fa fa-angle-down"></span>
        </button>
    </div>

    
    <div id="toc-collapse" class="navbar-collapse collapse card bg-secondary">
        <ul class="nav flex-column">
            
            <li class="nav-item" data-level="2"><a href="#background" class="nav-link">Background</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            
            <li class="nav-item" data-level="2"><a href="#risk-factors" class="nav-link">Risk factors</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            
            <li class="nav-item" data-level="2"><a href="#clinical-features" class="nav-link">Clinical features</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            
            <li class="nav-item" data-level="2"><a href="#differentials-of-lymphadenopathy" class="nav-link">Differentials of lymphadenopathy</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            
            <li class="nav-item" data-level="2"><a href="#investigations" class="nav-link">Investigations</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            
            <li class="nav-item" data-level="2"><a href="#serious-complications" class="nav-link">Serious complications</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            
            <li class="nav-item" data-level="2"><a href="#nhl" class="nav-link">NHL</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            
            <li class="nav-item" data-level="2"><a href="#dlbcl" class="nav-link">DLBCL</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            
            <li class="nav-item" data-level="2"><a href="#follicular-lymphoma" class="nav-link">Follicular lymphoma</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            
            <li class="nav-item" data-level="2"><a href="#hodgkin-lymphoma" class="nav-link">Hodgkin lymphoma</a>
              <ul class="nav flex-column">
              </ul>
            </li>
        </ul>
    </div>
</div></div>
                    <div class="col-md-9" role="main">

<h2 id="background">Background</h2>
<ul>
<li>lymphoid cell malignancies in predominantly lymphoid tissue (nodes, spleen, marrow)</li>
<li>classification based on<ul>
<li>morphology</li>
<li>immunophenotype</li>
<li>cytogenetics</li>
<li>molecular testing</li>
<li>clinical factors</li>
</ul>
</li>
<li>Non-Hodgkin lymphoma<ul>
<li>B-cell<ul>
<li>precursor vs. mature</li>
</ul>
</li>
<li>T and NK cells<ul>
<li>precursor vs. mature</li>
</ul>
</li>
</ul>
</li>
<li>Hodgkin lymphoma<ul>
<li>Classical<ul>
<li>nodular sclerosis</li>
<li>mixed cellularity</li>
<li>lymphocyte rich</li>
<li>lymphocyte depleted</li>
</ul>
</li>
<li>Nodular lymphocyte predominant Hodgkin lymphoma</li>
</ul>
</li>
</ul>
<p><img alt="" src="../../figures/Pasted%20image%2020231025152659.png" />
- B-cell
    - precursor B-cell in BM
    - goes into circulation, encounters antigen
    - reaches germinal centre - clas sswitch, somatic hypermutation, etc. and matures
        - majority of B-cell NHL and HL come from germinal centre
    - leaves germinal centre into mature b-cell or plasma cell
- T-cell
    - BM stem cell to thymus
    - reaches periphery</p>
<h2 id="risk-factors">Risk factors</h2>
<ul>
<li>Exposures<ul>
<li>occupational - farmers (Mantle cell)</li>
<li>environmental</li>
<li>prior RT, chemotherapy </li>
</ul>
</li>
<li>Immune dysfunction<ul>
<li>autoimmune disease</li>
<li>immunodeficiency/HIV</li>
<li>immune suppression/ post-transplant (EBV associated lymphoma)</li>
</ul>
</li>
<li>Genetics - 12-30% have family history</li>
<li>infectious assocations<ul>
<li>EBV: Burkitt lymphoma (100% in africans), DLBCL, NK-Tcell lymphoma (aggressive, nasal passage lymphoma), Hodgkin lymphoma, Plasmablastic lymphoma (rare, immunocompromised, typically HPV)</li>
<li>HTLV-1: Adult T-cell leukemia/lymphoma (presents with hypercalcaemia++)</li>
<li>HHV-8: Primary effusion lymphoma, LB-cell lymphoma associated with Castlemans</li>
<li>Marginal zone lymphoma - assoc w/ H.pylori (Gastric MALT - chronic inflammation stimulates B-cell clonal stimulation), B burgdorferi (skin MALT), Hepatitic C (splenic marginal zone lymphoma), C. jejuni</li>
</ul>
</li>
</ul>
<h2 id="clinical-features">Clinical features</h2>
<ul>
<li>Lymphadenopathy (2/3)</li>
<li>B-symptoms - Fever &gt; 38, drenching night sweat, 10% weight loss in 6mo<ul>
<li>more common in HL and aggressive NHL</li>
<li>reflects burden of disease and how fast its growing</li>
</ul>
</li>
<li>NHL <ul>
<li>extra-nodal site affected - GI tract, skin, bone</li>
<li>rare - testicles (older), thyroid, kidney, bladder, adrenal, heart, lung, breast</li>
</ul>
</li>
</ul>
<h2 id="differentials-of-lymphadenopathy">Differentials of lymphadenopathy</h2>
<ul>
<li>infection - EBV, CMV, bacterial</li>
<li>Medications - dilantin, sulfonamides, penicillin, hydralazine; particularly antiepileptics</li>
<li>Rheumatologic - Lupus, RA, Still's disease, Churg-Strauss<ul>
<li>association with rheumatic dx and development of lymphoma too</li>
<li>need to watch; progressive or out of proportion adenopathy â†’ should biopsy still</li>
</ul>
</li>
<li>Other - sarcoid, kikuchi disease (necrotising granulomatous disease in neck), amyloidosis, chronic sranulomatous disease, Castleman's disease</li>
</ul>
<h2 id="investigations">Investigations</h2>
<ul>
<li>Biopsy<ul>
<li>FNA is NOT adequate to see architecture of tissue and need tissue for immunochemistry and further studies</li>
<li>Supraclavicular nodes &gt; Cervical/axillary &gt; inguinal<ul>
<li>supraclavicular nodes typically NOT infective, and can heal up well</li>
<li>inguinal node drains large part of body so don't want to be left with lymphoedema</li>
</ul>
</li>
<li>aim for excisional biopsy &gt; CT guided core biopsy</li>
<li>sent for pathology, IHC, flow cytometry<ul>
<li>negative flow cytometry does not mean NO lymphoma â†’ large cells do not flow well </li>
</ul>
</li>
</ul>
</li>
<li>Staging scans - CT CAP +/- PET <ul>
<li>PET for metabolically active tumor</li>
</ul>
</li>
<li>BMB</li>
<li>FBC + film, EUC, LFT, uric acid, CMP<ul>
<li>b2 microglobulin for indolent lymphoma</li>
<li>LDH for burden of fast growing lymphoma - note can be elevated for many reasons</li>
<li>SPEP - CLL/SLL/waldenstrom's/lymphoplasmacytoid - baseline level of Igs (send in B-cell lymphomas)</li>
</ul>
</li>
</ul>
<h2 id="serious-complications">Serious complications</h2>
<ul>
<li>Cord compression<ul>
<li>if suspecting lymphoma - expedite tissue ASAP</li>
</ul>
</li>
<li>pericardial disease/tamponade - in aggressive NHL involving mediastinum, and HL<ul>
<li>once therapy started, tamponade will typically resolve</li>
</ul>
</li>
<li>hypercalcaemia - typically from 1,25(OH)D related; macrophages in tumour microenvironment will hydroxylate vitamin D</li>
<li>SVC/airway compromise - same patients as tamponade patients (mediastinal lymphoma)</li>
<li>hyperviscosity syndrome - typically in Waldenstrom's (IgM production) <ul>
<li>rituximab treatment of Wadenstrom's can result in transient hyperviscosity</li>
<li>visual changes, headache, mental status change, dyspnoea</li>
</ul>
</li>
<li>intestinal obstruction - mass effect</li>
<li>ureteral obstruction - mass effect</li>
<li>tumor lysis syndrome - Burkitt's may present with spontaneous TLS, but not typical<ul>
<li>allopurinol and IV fluids treat majority; rasburicase may need to be use</li>
</ul>
</li>
<li>ITP/AIHA</li>
</ul>
<h2 id="nhl">NHL</h2>
<p>Epidemiology
- 7th most common cause of cancer
- mAge 67</p>
<table>
<thead>
<tr>
<th></th>
<th>Indolent</th>
<th>Aggressive</th>
<th>Highly aggressive</th>
</tr>
</thead>
<tbody>
<tr>
<td>Survival untreated</td>
<td>Years</td>
<td>Months</td>
<td>Weeks</td>
</tr>
<tr>
<td>Response to chemotherapy</td>
<td>Not curable</td>
<td>Curative</td>
<td>Curative</td>
</tr>
<tr>
<td>Example</td>
<td>Follicular lymphoma</td>
<td>DLBCL</td>
<td>Burkitt lymphoma</td>
</tr>
</tbody>
</table>
<ul>
<li>Indolent lymphomas - slow growing, incidentally picked up (imaging for other reasons)<ul>
<li>B-cell lymphomas<ul>
<li>B-cell CLL/SLL - <ul>
<li>if disease in blood and &gt; 5000 circulating tumor cells = CLL</li>
<li>&lt; 5000 in blood, in nodes and marrow â†’ SLL</li>
</ul>
</li>
<li>Lymphoplasmacytic / Waldenstroms</li>
<li>Hairy cell leukiema</li>
<li>Follicular (gr 1-2) - 20 year median survival</li>
<li>Marginal zone<ul>
<li>Nodal - acts like follicular</li>
<li>Extranodal (MALT) - favourable, can be treated with focal radiation</li>
<li>Splenic - splenomegaly, cytopenia</li>
</ul>
</li>
<li>Mantle cell - halfway between indolent and aggressive<ul>
<li>7-8 year median survival</li>
</ul>
</li>
<li>Plasma cell myeloma - most mature type of B-cell lymphoma</li>
</ul>
</li>
<li>T-cell lymphoma<ul>
<li>T-cell large granular lymphocyte leukemia - indolent disease on spectrum of Felty's syndrome<ul>
<li>often do not need therapy and can be watched unelss become neutropenic/anaemic</li>
</ul>
</li>
<li>mycosis fungoides</li>
</ul>
</li>
</ul>
</li>
<li>Aggressive lymphomas<ul>
<li>DLBCL</li>
<li>Follicular lymphomas (grade 3) - grade = size of cells on microscopy</li>
<li>Peripheral T-cell lymphoma - 15% of NHLs, difficult to treat with many subtypes</li>
<li>Anaplastic Large cell lymphoma - subset of peripheral T-cell lymphoma<ul>
<li>Alk positive (in kids) is favourable</li>
</ul>
</li>
<li>NK/T lymphoma - aggressive</li>
</ul>
</li>
<li>Highly aggressive<ul>
<li>Burkitt lymphoma</li>
<li>Adult T-cell lymphoma/leukemia (HTLV-1 associated)</li>
<li>Precursor B-lymphoblastic lymphoma (synonymous with B-cell ALL)</li>
<li>Precursor T-lymphoblastic lymphoma</li>
</ul>
</li>
</ul>
<h2 id="dlbcl">DLBCL</h2>
<ul>
<li>Most common NHL in adults - 25%</li>
<li>mAge 65, M&gt;F</li>
<li>Management<ul>
<li>CHOP (1970s)</li>
<li>1980s - 2nd and 3rd gen regimens with improved CR rates and survivals in pilot studies, but no benefit in RCT compared to CHOP</li>
<li>rituximab (anti-CD20) - ADCC by NK-cell activated (tumor cell killing) + complement mediated toxicity + direct killing (poorly understood)<ul>
<li>R-CHOP improved overall survival</li>
</ul>
</li>
</ul>
</li>
<li>Prognosis<ul>
<li>65-70% chance of cure with R-CHOP</li>
<li>Determined by international prognostic index determines risk and chance of cure</li>
<li>Gene expression profiling also available<ul>
<li>activated B-cell type vs, Germinal center B-cell type, primary mediastinal subtype<ul>
<li>germinal centre B-cell type better PFS vs. activated B-cell like</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<p><img alt="" src="../../figures/Pasted%20image%2020231025155441.png" />
<img alt="" src="../../figures/Pasted%20image%2020231025155504.png" /></p>
<hr />
<h2 id="follicular-lymphoma">Follicular lymphoma</h2>
<ul>
<li>2nd most common NHL (20%)</li>
<li>seen as large follicles under microscope</li>
<li>mAge 60, F&gt;M (1.17:1)</li>
<li>typically presents disseminated disease; 20% may have stage I disease (BMB to prove it is localised)<ul>
<li>half cured in stage I disease with RTx</li>
<li>advanced but low burden â†’ no benefit to treating early if asymptomatic with low burden â†’ observation<ul>
<li>same rate of histological transformation, no survival disadvantage</li>
<li>can sometimes see spontaneous remission</li>
</ul>
</li>
<li>advanced but high burden â†’ therapy <ul>
<li>cytopenias secondary to BM infiltration</li>
<li>threatened end-organ dysfunction - relatively uncommon</li>
<li>symptomatic disease</li>
<li>bulky disease (&gt; 10cm)</li>
<li>steady progression during period of observation &gt; 6mo</li>
<li>concurrent histologic transformation - treat as DLBCL</li>
<li>massive splenomegaly </li>
</ul>
</li>
</ul>
</li>
<li>Therapy options<ul>
<li>rituximab + chemotherapy<ul>
<li>low burden has good response to rituximab alone</li>
<li>Chemo: Bendamustine vs. CHOP</li>
</ul>
</li>
<li>maintenance rituximab - keep in remission longer, no benefit on OFS</li>
<li>Novel agents - lenalidomide (iMib), idelalisib </li>
<li>stem cell transplant MAY be curative in subset of patients with relapsed/refractory disease<ul>
<li>if comes back â†’ get back in remission â†’ then try SCT</li>
</ul>
</li>
</ul>
</li>
</ul>
<hr />
<h2 id="hodgkin-lymphoma">Hodgkin lymphoma</h2>
<ul>
<li>Reed-sternberg cells - germinal centre B-cells that cannot make Ig</li>
<li>rarer than NHL</li>
<li>mAge 39</li>
<li>increased incidence in industrialised world<ul>
<li>seen more common in eldest child</li>
<li>nodular sclerosis subtype in USA, high SES</li>
<li>mixed cellularity/lymphocyte depleted seen in immunocompromised and lower SES countries</li>
</ul>
</li>
<li>Clinical features<ul>
<li>Fever including classic Pel-Ebstein - cyclical fevers</li>
<li>drenching night sweats 25%</li>
<li>pruritis 10-15% - no rash until excoriation</li>
<li>Lymphadenopathy - neck/mediastinum most common<ul>
<li>abdominal/groin pain</li>
<li>alcohol induced pain - cytokine mediated?</li>
</ul>
</li>
<li>rarely jaundiced or severe abdominal pain</li>
</ul>
</li>
<li>approach to management<ul>
<li>consider competing risks - relapses occur within the first 5 years, but secondary complications (malignancy, cardiac) arise late and increase risk over time</li>
<li>complications<ul>
<li>fertility - ABVD low risk for infertility</li>
<li>pulmonary toxicity - bleomycin (fibrosis/pneumonitis) and mediastinal RT</li>
<li>cardiotoxicity - mediastinal RT (pericardial, valvular, CAD), doxorubicin (cardiomyopathy)</li>
<li>secondary malignancies - solid tumors from radiation - breast, lung, etc.</li>
</ul>
</li>
<li>Chemotherapy - ABVD - adriamycin, bleomycin, vinclastine, dacarbaxine</li>
<li>Radiotherapy - field radiation</li>
<li>Stage I and II disease<ul>
<li>Chemo +/- radio - ~90% cured with chemotherapy alone</li>
</ul>
</li>
<li>Stage III and IV disease<ul>
<li>chemo always, radiation for bulky disease - 75% cured with initial therapy</li>
</ul>
</li>
<li>new drugs<ul>
<li>brentuximab vedotin - Ab drug conjugate<ul>
<li>CD30 (reed sternberg cell) antibody</li>
<li>deliver microtubule inhibitor direct to cells</li>
<li>75% response rate, especially in relapsed or refractory disease</li>
<li>5% difference in relapse rate; not too much better (NEJM 2017 Connors et al)</li>
</ul>
</li>
<li>immunotherapy - PD1/PDL1<ul>
<li>Reed-sternberg has amplications at 9p24.1 - overexpressed PDL1-PDL2</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul></div>
            </div>
        </div>

        <footer class="col-md-12">
            <hr>
                <p>Copyright &copy; 2021 Weber Liu</p>
            <p>Documentation built with <a href="https://www.mkdocs.org/">MkDocs</a>.</p>
        </footer>
        <script src="../../js/jquery-3.6.0.min.js"></script>
        <script src="../../js/bootstrap.min.js"></script>
        <script>
            var base_url = "../..",
                shortcuts = {"help": 191, "next": 78, "previous": 80, "search": 83};
        </script>
        <script src="../../js/base.js"></script>
        <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
        <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
        <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
        <script src="../../search/main.js"></script>

        <div class="modal" id="mkdocs_search_modal" tabindex="-1" role="dialog" aria-labelledby="searchModalLabel" aria-hidden="true">
    <div class="modal-dialog modal-lg">
        <div class="modal-content">
            <div class="modal-header">
                <h4 class="modal-title" id="searchModalLabel">Search</h4>
                <button type="button" class="close" data-dismiss="modal"><span aria-hidden="true">&times;</span><span class="sr-only">Close</span></button>
            </div>
            <div class="modal-body">
                <p>From here you can search these documents. Enter your search terms below.</p>
                <form>
                    <div class="form-group">
                        <input type="search" class="form-control" placeholder="Search..." id="mkdocs-search-query" title="Type search term here">
                    </div>
                </form>
                <div id="mkdocs-search-results" data-no-results-text="No results found"></div>
            </div>
            <div class="modal-footer">
            </div>
        </div>
    </div>
</div><div class="modal" id="mkdocs_keyboard_modal" tabindex="-1" role="dialog" aria-labelledby="keyboardModalLabel" aria-hidden="true">
    <div class="modal-dialog">
        <div class="modal-content">
            <div class="modal-header">
                <h4 class="modal-title" id="keyboardModalLabel">Keyboard Shortcuts</h4>
                <button type="button" class="close" data-dismiss="modal"><span aria-hidden="true">&times;</span><span class="sr-only">Close</span></button>
            </div>
            <div class="modal-body">
              <table class="table">
                <thead>
                  <tr>
                    <th style="width: 20%;">Keys</th>
                    <th>Action</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td class="help shortcut"><kbd>?</kbd></td>
                    <td>Open this help</td>
                  </tr>
                  <tr>
                    <td class="next shortcut"><kbd>n</kbd></td>
                    <td>Next page</td>
                  </tr>
                  <tr>
                    <td class="prev shortcut"><kbd>p</kbd></td>
                    <td>Previous page</td>
                  </tr>
                  <tr>
                    <td class="search shortcut"><kbd>s</kbd></td>
                    <td>Search</td>
                  </tr>
                </tbody>
              </table>
            </div>
            <div class="modal-footer">
            </div>
        </div>
    </div>
</div>

    </body>
</html>
